The Centers for Medicare and Medicaid Services ("CMS") published several
final rules in today's Federal Register publication that may be of interest to
our health care clients.
First, CMS published a final rule related to conditions of participation for
hospitals that transfuse blood and blood components. All hospitals that
transfuse blood and blood components must meet these new conditions of
participation in order to participate in the Medicare program. The final rule is
set forth at 73 FR 36469 et. seq.
Second, CMS published a final rule that sets forth the appeals process and
the timing for appeals for all suppliers and providers in case of such
provider's or supplier's enrollment or re-enrollment in the Medicare program or
revalidation of an application for Medicare billing being denied and billing
privileges being revoked. This final rule sets forth the process for appeal and
the timing for filing initial appeals, reconsideration, and for administrative
review. It is important for clients to understand this process in case their
enrollment or re-enrollment in Medicare is denied or the revalidation of their
application is denied. The final rule is set forth at 73 FR 36448 et. seq.
Finally, CMS published a final rule regarding the definition of hardship in
regard to repaying overpayments from CMS to providers or suppliers. This may
apply to clients that have received overpayments and are on extended repayment
schedules or that may qualify for extended repayment schedules under the new
definition of hardship. The final rule is set forth at 73 FR 36443 et. seq.
Helping our clients navigate the regulatory landscape is one of the services
provided by the McGuireWoods
Health Care Practice.
For more information about our work for clients, please visit our website.